CureVac N.V. (ETR:5CV)
Germany · Delayed Price · Currency is EUR 3.892
+0.014 (0.36%)
At close: Jan 5, 2026
CureVac Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Revenue | 70.74 | 535.18 | 53.76 | 67.42 | 102.99 | 48.87 |
Revenue Growth (YoY) | -86.98% | 895.54% | -20.26% | -34.54% | 110.74% | 180.61% |
Cost of Revenue | 4.75 | 105.63 | 116.21 | 158.97 | 215.27 | 14.17 |
Gross Profit | 65.99 | 429.55 | -62.45 | -91.55 | -112.28 | 34.7 |
Selling, General & Admin | 88.53 | 74.34 | 95.74 | 107.07 | 102.26 | 54.29 |
Research & Development | 154.87 | 153.03 | 115.72 | 62.55 | 815.91 | 113.81 |
Other Operating Expenses | -359.48 | -7.6 | -7.8 | -36.66 | -0.1 | 0.15 |
Operating Expenses | -116.08 | 219.77 | 203.67 | 132.96 | 918.07 | 168.25 |
Operating Income | 182.08 | 209.78 | -266.12 | -224.51 | -1,030 | -133.55 |
Interest Expense | -6.18 | - | - | -2.3 | -6.79 | -22.1 |
Interest & Investment Income | 12.76 | 12.36 | 2.02 | 15.41 | 0.08 | 2.07 |
Currency Exchange Gain (Loss) | 0.84 | 0.84 | -1.21 | 0.87 | 6.15 | - |
Other Non Operating Income (Expenses) | -0 | - | 13.43 | -13.68 | 0.32 | - |
EBT Excluding Unusual Items | 189.5 | 222.98 | -251.88 | -224.21 | -1,031 | -153.58 |
Merger & Restructuring Charges | -32.1 | -32.1 | - | - | - | - |
Asset Writedown | - | - | -8.09 | -24.95 | -22.81 | - |
Other Unusual Items | - | - | - | - | 640.9 | 23.74 |
Pretax Income | 157.4 | 190.88 | -259.97 | -249.16 | -412.5 | -129.85 |
Income Tax Expense | 28.57 | 28.7 | 0.2 | -0.13 | -0.78 | -0.73 |
Net Income | 128.82 | 162.19 | -260.17 | -249.03 | -411.72 | -129.12 |
Net Income to Common | 128.82 | 162.19 | -260.17 | -249.03 | -411.72 | -129.12 |
Shares Outstanding (Basic) | 161 | 224 | 221 | 189 | 186 | 132 |
Shares Outstanding (Diluted) | 161 | 224 | 221 | 189 | 186 | 132 |
Shares Change (YoY) | -38.70% | 1.57% | 16.84% | 1.65% | 40.71% | 36.72% |
EPS (Basic) | 0.80 | 0.72 | -1.18 | -1.32 | -2.21 | -0.98 |
EPS (Diluted) | 0.80 | 0.72 | -1.18 | -1.32 | -2.21 | -0.98 |
Free Cash Flow | -124.13 | 87.54 | -320.21 | -374.2 | -857.35 | 486.07 |
Free Cash Flow Per Share | -0.77 | 0.39 | -1.45 | -1.98 | -4.61 | 3.68 |
Gross Margin | 93.29% | 80.26% | -116.17% | -135.79% | -109.02% | 71.00% |
Operating Margin | 257.38% | 39.20% | -495.04% | -333.00% | -1000.44% | -273.27% |
Profit Margin | 182.11% | 30.30% | -483.96% | -369.37% | -399.76% | -264.21% |
Free Cash Flow Margin | -175.47% | 16.36% | -595.64% | -555.03% | -832.46% | 994.61% |
EBITDA | 193.69 | 222.56 | -249.33 | -205.82 | -1,020 | -123.1 |
EBITDA Margin | 273.81% | 41.59% | - | - | - | -251.88% |
D&A For EBITDA | 11.62 | 12.78 | 16.79 | 18.69 | 10.31 | 10.46 |
EBIT | 182.08 | 209.78 | -266.12 | -224.51 | -1,030 | -133.55 |
EBIT Margin | 257.38% | 39.20% | - | - | - | -273.27% |
Effective Tax Rate | 18.15% | 15.03% | - | - | - | - |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.